MCR Health, INC.
MCR Health, INC. was paid $25.93M by Medicaid between Jan 2018 and Dec 2024, across 255 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 22% of everything it billed.
ARCADIA, FL 34266
Next to other Psychologist providers in Florida
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 155,690 | $40K | |
| 2019 | 439,394 | $3.80M | |
| 2020 | 331,116 | $4.33M | |
| 2021 | 361,662 | $5.24M | |
| 2022 | 297,436 | $4.35M | |
| 2023 | 191,274 | $2.88M | |
| 2024incomplete | 397,485 | $5.30M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 22% | 136,856 | 123,793 | $5.68M |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 12% | 260,292 | 103,284 | $3.10M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11% | 102,781 | 92,224 | $2.79M |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 6.9% | 155,619 | 97,852 | $1.79M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.0% | 22,323 | 21,474 | $1.56M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.6% | 19,721 | 18,423 | $1.44M |
| H1000 | Prenatal care, at-risk assessment | 5.5% | 27,908 | 19,267 | $1.43M |
| 99308 | Subsequent nursing facility care, per day, straightforward | 4.0% | 110,933 | 82,421 | $1.05M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.9% | 14,711 | 13,983 | $1000K |
| 59410 | 2.4% | 645 | 584 | $625K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.2% | 8,277 | 7,888 | $571K |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | 1.3% | 10,286 | 9,196 | $334K |
243 more codes
| 99349 | 1.1% | 8,194 | $296K | |
| 87428 | 1.1% | 10,217 | $288K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.0% | 51,881 | $265K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 11,040 | $240K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 26,492 | $211K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 12,737 | $204K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 2,711 | $199K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 8,978 | $177K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 7,493 | $169K |
| 59430 | <1% | 2,720 | $169K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 1,659 | $167K |
| 99307 | <1% | 30,191 | $138K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 5,097 | $134K |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | <1% | 1,103 | $94K |
| 99335 | <1% | 4,668 | $87K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 196 | $83K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 1,138 | $79K |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 2,651 | $78K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 989 | $75K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 1,671 | $66K |
| 92558 | <1% | 26,394 | $61K | |
| D0330 | Panoramic radiographic image | <1% | 1,453 | $61K |
| D1110 | Prophylaxis - adult | <1% | 1,523 | $60K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 767 | $59K |
| 59025 | Fetal non-stress test | <1% | 1,079 | $57K |
| G0470 | Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit | <1% | 91,704 | $54K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 786 | $53K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 3,053 | $50K |
| D0274 | Bitewings - four radiographic images | <1% | 2,664 | $47K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 4,160 | $45K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 921 | $45K |
| 36475 | <1% | 96 | $43K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 403 | $42K |
| G0467 | Community health center visit, returning patient | <1% | 61,958 | $39K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,847 | $32K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 10,980 | $29K |
| 59515 | <1% | 27 | $24K | |
| D0120 | Dental checkup, returning patient | <1% | 1,546 | $23K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 8,901 | $22K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 449 | $21K |
| 99336 | <1% | 905 | $21K | |
| 99460 | <1% | 399 | $20K | |
| 93970 | <1% | 285 | $20K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,505 | $20K |
| 83655 | <1% | 4,333 | $19K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 24,712 | $19K |
| 99381 | <1% | 234 | $17K | |
| 81025 | <1% | 8,037 | $17K | |
| 90474 | <1% | 3,248 | $17K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 444 | $16K |
| 90837 | Psychotherapy session, about an hour | <1% | 1,094 | $15K |
| 85018 | <1% | 15,627 | $14K | |
| 93224 | <1% | 267 | $14K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 150 | $13K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 267 | $13K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 189 | $13K |
| 36465 | <1% | 16 | $12K | |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 186 | $11K |
| 11981 | <1% | 14 | $10K | |
| D0140 | Limited oral evaluation - problem focused | <1% | 770 | $10K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 254 | $10K |
| 3074F | <1% | 69,711 | $9K | |
| 99223 | Prolong inpt eval add15 m | <1% | 107 | $9K |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 1,012 | $7K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 175 | $7K |
| D1206 | Topical application of fluoride varnish | <1% | 1,813 | $6K |
| D1330 | <1% | 1,800 | $6K | |
| 93015 | <1% | 403 | $6K | |
| D1351 | Sealant - per tooth | <1% | 362 | $6K |
| L3000 | Foot, insert, removable, molded to patient model, 'ucb' type, berkeley shell, each | <1% | 13 | $5K |
| 90686 | <1% | 11,879 | $4K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 52 | $4K |
| 11102 | <1% | 54 | $4K | |
| 17110 | <1% | 53 | $3K | |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 8,370 | $3K |
| 90633 | <1% | 5,771 | $3K | |
| 99383 | <1% | 32 | $3K | |
| D0220 | Intraoral - periapical first radiographic image | <1% | 3,885 | $3K |
| 96160 | <1% | 33,231 | $3K | |
| 11721 | <1% | 334 | $2K | |
| 90681 | <1% | 3,275 | $2K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 38 | $2K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | <1% | 14 | $2K |
| 90715 | <1% | 440 | $2K | |
| D1354 | <1% | 242 | $2K | |
| 0071A | <1% | 146 | $2K | |
| G0127 | Trimming of dystrophic nails, any number | <1% | 807 | $2K |
| 0002A | <1% | 140 | $2K | |
| 0072A | <1% | 66 | $2K | |
| 93923 | <1% | 29 | $2K | |
| 3075F | <1% | 8,202 | $2K | |
| 90651 | <1% | 3,242 | $2K | |
| 81002 | <1% | 12,981 | $1K | |
| 81003 | <1% | 1,059 | $1K | |
| 11104 | <1% | 18 | $1K | |
| G0469 | Federally qualified health center (fqhc) visit, mental health, new patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit | <1% | 3,492 | $1K |
| 93000 | <1% | 780 | $1K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 42 | $1K |
| 96136 | <1% | 25 | $1K | |
| 90656 | <1% | 2,307 | $1K | |
| 94729 | <1% | 32 | $1K | |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 535 | $1K |
| 99384 | <1% | 14 | $1K | |
| 99348 | <1% | 123 | $1K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 573 | $1K |
| 0001A | <1% | 115 | $1K | |
| 94060 | <1% | 42 | $1K | |
| 93244 | <1% | 88 | $992.57 | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 150 | $986.83 |
| 94727 | <1% | 54 | $982.80 | |
| 86850 | <1% | 221 | $976.88 | |
| 0011A | <1% | 43 | $945.30 | |
| 90723 | <1% | 7,691 | $936.66 | |
| 73630 | <1% | 194 | $865.08 | |
| D1120 | Dental cleaning, child | <1% | 50 | $840.44 |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 32 | $704.55 |
| 90710 | <1% | 3,698 | $678.79 | |
| 92015 | Determination of refractive state | <1% | 337 | $628.42 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 12 | $606.86 |
| 3079F | <1% | 21,435 | $600.10 | |
| 99173 | <1% | 26,243 | $595.14 | |
| 11056 | <1% | 30 | $590.23 | |
| 99441 | <1% | 131 | $561.39 | |
| 99000 | <1% | 32,340 | $497.98 | |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 43 | $454.63 |
| G0124 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | <1% | 424 | $443.20 |
| 1160F | <1% | 61,010 | $436.89 | |
| 99334 | <1% | 16 | $420.00 | |
| 80305 | <1% | 706 | $419.85 | |
| 92250 | <1% | 42 | $368.94 | |
| 90647 | <1% | 7,740 | $345.03 | |
| 0012A | <1% | 12 | $344.00 | |
| 85610 | <1% | 58 | $338.11 | |
| 96127 | <1% | 609 | $300.64 | |
| 99442 | <1% | 17 | $297.39 | |
| 90662 | <1% | 15 | $275.00 | |
| 1125F | <1% | 17,234 | $274.67 | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 93 | $233.94 |
| 1126F | <1% | 58,122 | $207.07 | |
| 97802 | <1% | 15 | $195.72 | |
| 0500F | <1% | 796 | $188.07 | |
| 90670 | <1% | 8,256 | $184.03 | |
| D0190 | <1% | 18 | $180.00 | |
| 99406 | <1% | 44 | $172.86 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 6,098 | $152.57 |
| 99483 | Prolong outpt/office vis | <1% | 469 | $146.86 |
| 82962 | <1% | 442 | $142.70 | |
| 93242 | <1% | 129 | $131.63 | |
| 1036F | <1% | 48,172 | $131.22 | |
| 90685 | <1% | 206 | $126.62 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 60,334 | $115.72 |
| 1124F | <1% | 1,685 | $109.12 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | <1% | 2,637 | $109.06 |
| 1158F | <1% | 773 | $107.65 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 16 | $100.00 |
| 3080F | <1% | 2,897 | $92.72 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 506 | $89.36 |
| 87807 | <1% | 129 | $85.50 | |
| 0502F | <1% | 21,308 | $84.96 | |
| 92228 | <1% | 78 | $76.68 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 16 | $64.96 |
| 3046F | <1% | 2,433 | $58.05 | |
| 36410 | <1% | 556 | $55.01 | |
| 3078F | <1% | 55,060 | $51.55 | |
| 90674 | <1% | 168 | $50.05 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 30 | $46.80 |
| 90620 | <1% | 640 | $40.00 | |
| 3044F | <1% | 239 | $40.00 | |
| 81001 | <1% | 34 | $37.10 | |
| 1159F | <1% | 21,255 | $36.86 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 15 | $35.31 |
| 93017 | <1% | 55 | $32.38 | |
| 90696 | <1% | 549 | $30.03 | |
| D0272 | Bitewings - two radiographic images | <1% | 49 | $30.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 119 | $23.40 |
| 90734 | <1% | 1,561 | $20.00 | |
| 82043 | <1% | 21 | $15.81 | |
| 99421 | <1% | 34 | $15.00 | |
| 90700 | <1% | 749 | $10.04 | |
| D0603 | <1% | 237 | $5.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | <1% | 51,781 | $3.83 |
| 3008F | <1% | 7,132 | $2.84 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 37 | $0.56 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 20,267 | $0.08 |
| 2028F | <1% | 1,464 | $0.04 | |
| 3016F | <1% | 6,234 | $0.02 | |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | <1% | 644 | $0.01 |
| 0503F | <1% | 2,675 | $0.01 | |
| 3077F | 0% | 5,599 | $0.00 | |
| 0521F | 0% | 5,203 | $0.00 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 1,540 | $0.00 |
| 99177 | 0% | 2,735 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 855 | $0.00 |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 393 | $0.00 |
| 90671 | 0% | 630 | $0.00 | |
| G8598 | Aspirin or another antiplatelet therapy used | 0% | 998 | $0.00 |
| 4013F | 0% | 634 | $0.00 | |
| V2020 | Frames, purchases | 0% | 99 | $0.00 |
| 99310 | Prolong nursin fac eval 15m | 0% | 106 | $0.00 |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 0% | 12 | $0.00 |
| G8935 | Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy | 0% | 833 | $0.00 |
| 1100F | 0% | 165 | $0.00 | |
| G8511 | Screening for depression documented as positive, follow-up plan not documented, reason not given | 0% | 158 | $0.00 |
| 90461 | 0% | 12 | $0.00 | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 0% | 101 | $0.00 |
| 99080 | 0% | 28 | $0.00 | |
| 80061 | Lipid panel | 0% | 84 | $0.00 |
| 80074 | 0% | 13 | $0.00 | |
| 91300 | 0% | 22 | $0.00 | |
| 99306 | Prolong nursin fac eval 15m | 0% | 31 | $0.00 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 20 | $0.00 |
| 84439 | 0% | 13 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 36,372 | $0.00 |
| 36416 | 0% | 4,990 | $0.00 | |
| 1034F | 0% | 8,772 | $0.00 | |
| 4000F | 0% | 2,361 | $0.00 | |
| 4008F | 0% | 531 | $0.00 | |
| D1310 | 0% | 1,160 | $0.00 | |
| 90677 | 0% | 1,809 | $0.00 | |
| 0501F | 0% | 1,526 | $0.00 | |
| 2010F | 0% | 2,012 | $0.00 | |
| 80053 | Comprehensive metabolic panel | 0% | 135 | $0.00 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 76 | $0.00 |
| 1170F | 0% | 148 | $0.00 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 103 | $0.00 |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 143 | $0.00 |
| 1111F | 0% | 196 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 108 | $0.00 |
| G9432 | Asthma well-controlled based on the act, c-act, acq, or ataq score and results documented | 0% | 204 | $0.00 |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 0% | 13 | $0.00 |
| 2023F | 0% | 84 | $0.00 | |
| 87536 | 0% | 13 | $0.00 | |
| G8755 | Most recent diastolic blood pressure >= 90 mmhg | 0% | 68 | $0.00 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 13 | $0.00 |
| 87081 | 0% | 42 | $0.00 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 0% | 28 | $0.00 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 0% | 24 | $0.00 |
| 91307 | 0% | 67 | $0.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 39 | $0.00 |
| 0513F | 0% | 18 | $0.00 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 64 | $0.00 |
| 3060F | 0% | 28 | $0.00 | |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| MCR Health, INC. | Venice, FL | $699K |
| MCR Health, INC. | Arcadia, FL | $355K |
| MCR Health, INC. | Wauchula, FL | $23K |
| MCR Health, INC. | Arcadia, FL | $10K |
| MCR Health, INC. | Bradenton, FL | $5K |
| MCR Health, INC. | Sarasota, FL | $807.91 |
| MCR Health, INC. | Bradenton, FL | $683.08 |
| MCR Health, INC. | Arcadia, FL | $259.82 |
| MCR Health, INC. | Bradenton, FL | $181.15 |
| MCR Health, INC. | Sarasota, FL | $0.00 |
| MCR Health, INC. | Bradenton, FL | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.